Document Detail

Secondary prevention strategies in ischemic stroke: identification and optimal management of modifiable risk factors.
MedLine Citation:
PMID:  15473419     Owner:  NLM     Status:  MEDLINE    
The identification and treatment of modifiable Ischemic stroke risk factors, in addition to appropriate antithrombotic therapy, can reduce the likelihood of first or recurrent stroke, prevent long-term morbidity and mortality after first stroke or transient Ischemic attack, and lower health care costs. Long-term morbidity and mortality in patients with ischemic stroke includes patients with coronary artery disease. Therefore, in patients with ischemic stroke (especially those with carotid artery disease and lacunar disease), the goal is to prevent not only recurrent stroke but also coronary artery disease. Neurologists and general practitioners must be aware of the specific risk factors and recommendations for patients with ischemic stroke and apply the information systematically. We review known risk factors for ischemic stroke and current recommendations for treatment, focusing primarily on atherosclerotic risk factors as they apply to patients with stroke. In particular, recent data on hypertension and hyperlipidemia are described. In addition, we discuss the challenges in managing these risk factors and the potential strategies for overcoming them.
Kelly D Flemming; Robert D Brown
Related Documents :
15316249 - Relationship between supra-annual trends in influenza rates and stroke occurrence.
12639199 - Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis ...
17878729 - Frequency and significance of cardiac sources of embolism in the toast classification.
19682409 - Epileptiform discharges and neuronal plasticity in the acute peri-infarct cortex of rats.
17845919 - Echocardiography in patients with symptomatic intracranial stenosis.
9236329 - Is an integrated approach warranted for concomitant carotid and coronary artery disease?
508249 - The value of echocardiography in assessing the severity of mitral stenosis.
10468079 - Early temporal changes in coronary flow velocity patterns in patients with acute myocar...
23366919 - Architecture design of the multi-functional wavelet-based ecg microprocessor for realti...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  79     ISSN:  0025-6196     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-11     Completed Date:  2004-11-23     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1330-40     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Ischemia / complications*,  prevention & control
Fibrinolytic Agents / therapeutic use
Recurrence / prevention & control
Risk Factors
Stroke / etiology,  prevention & control*
Reg. No./Substance:
0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Literature-searching strategies to improve the application of evidence-based clinical practice princ...
Next Document:  Gender theory and politics: historical fragments and current challenges